Homing of granulocytes transfused in perineal cellulitis in a RAC2 deficiency child monitored by chimerism quantification methods.


Journal

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
ISSN: 1953-8022
Titre abrégé: Transfus Clin Biol
Pays: France
ID NLM: 9423846

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 16 09 2020
revised: 08 03 2022
accepted: 09 03 2022
pubmed: 26 3 2022
medline: 24 8 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

Granulocyte transfusions can be used to treat infections when appropriate antibiotic and anti-fungal drugs have proved ineffective. We report a case of clinical efficacy of 18 granulocyte transfusions for perineal cellulitis in a 3-week-old RAC2-deficient newborn girl. This RAC2 deficiency is characterized by severe phagocyte defects including defective superoxide formation, adhesion and chemotaxis deficiency. In order to check that the granulocytes infused had reached the lesion site, the infiltration of donor cells was quantified by next generation sequencing (NGS) and digital droplet PCR after identification of DNA specific markers for donor and patient. After the 6th transfusion, 20% circulating cells and 55% cells isolated by swabbing from the lesion site were donor cells, confirming the infiltration of polynuclear cells in the perineal lesion site. These results strengthen the indication of granulocyte transfusions, and its continuation until the healing process of the skin is complete. This clinical case report highlights the potential efficacy of granulocyte transfusions to treat skin lesions in RAC2-deficient patients, a process which could be monitored by molecular biology tools for chimerism quantification.

Identifiants

pubmed: 35331893
pii: S1246-7820(22)00033-7
doi: 10.1016/j.tracli.2022.03.002
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-268

Informations de copyright

Copyright © 2022 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

P Pedini (P)

Immunogenetic Laboratory, EFS PACC, 149, Bd Baille, 13005 Marseille, France. Electronic address: pascal.pedini@efs.sante.fr.

A Sterin (A)

Department of Pediatric Hematology and Oncology, Timone Children Hospital, 278, Rue Saint-Pierre, 13005 Marseille, France.

C Clapasson (C)

Immunohematology laboratory, EFS PACC, 149, Bd Baille, 13005 Marseille, France.

C Picard (C)

Immunogenetic Laboratory, EFS PACC, 149, Bd Baille, 13005 Marseille, France; Aix Marseille Univ, CNRS, EFS, ADES, 27, Boulevard Jean Moulin, 13385 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH